Particle.news

Victoria’s Secret Adopts Poison Pill to Thwart Potential BBRC Takeover

The move comes as BBRC International nears regulatory clearance to increase its stake beyond 13%, raising takeover concerns.

Overview

  • Victoria’s Secret has implemented a one-year shareholder rights plan to prevent acquisitions without a control premium.
  • The poison pill activates if any shareholder exceeds a 15% stake, allowing others to purchase stock at a discount.
  • BBRC International, led by Brett Blundy, currently holds a 13% stake and could increase its position to 49.99% after the Hart-Scott-Rodino Act waiting period ends on May 21, 2025.
  • The board, chaired by Donna James, has engaged in discussions with BBRC while focusing on brand strategy under new CEO Hillary Super.
  • Victoria’s Secret shares rose 3.2% in premarket trading following the announcement of the poison pill plan.